China to Cut Import Tariffs on Select Commodities and Medical Products from 2026

China has announced a series of import tariff adjustments that will take effect from next year, signalling a targeted move to reduce costs for specific industries and healthcare segments, as per Reuters. 

Key Development 

As per a statement issued by the Customs Tariff Commission, the country will lower import duties on certain resource-based commodities, including recycled black powder used in lithium-ion battery production. The changes form part of a broader review of China’s tariff structure for 2026. 

Sector-wise Impact 

In addition to industrial inputs, China will also lower tariffs on certain medical products. These include artificial blood vessels and diagnostic kits used for detecting specific infectious diseases.  

Officials said the adjustments are intended to support the domestic healthcare system by improving the availability and affordability of advanced medical equipment and testing solutions. 

The tariff relief is expected to benefit hospitals, medical device manufacturers, and research institutions by reducing procurement costs and supporting innovation in medical technology. 

Trade Framework Update 

The commission said provisional import tariff rates for 935 products will be set below the most-favoured-nation (MFN) rates applied to other members of the World Trade Organization.  

These lower rates will apply on a temporary basis, indicating focused policy support rather than a blanket tariff cut. 

Read More: India's Russian Oil Imports Decline, US Imports Rise in 2025! 

Conclusion 

China’s tariff revisions point to a selective easing of import costs for strategic industrial and medical inputs, while maintaining alignment with its multilateral trade commitments. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.  

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.